Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA

PHASE3CompletedINTERVENTIONAL
Enrollment

604

Participants

Timeline

Start Date

June 12, 2014

Primary Completion Date

October 19, 2015

Study Completion Date

June 16, 2016

Conditions
Knee Osteoarthritis
Interventions
DRUG

chondroitin sulfate

DRUG

celecoxib

DRUG

placebo

Trial Locations (16)

4020

Unité d'exploration du metabolism osseux, CHU, Polyclinique universitaires L-Brull, Liège

Unknown

Ortopedicka Ambulance, Brno

Interni a revmatologicka ordinace, Břeclav

Vesalion s.r.o., Ostrava

Revmatologicky ustav, Prague

Thomayerova nemocnice - Revmatologicke a rehabilitacne oddeleni, Praha - Krc

Medical Plus, Uherské Hradiště

Azienda Osp. Univ. Di Careggi, Florence

Klinika Zdrowej Kosci, Lodz

Lubelskie Centrum Diagnostyczne, Świdnik

SOLB, Ul. Jana III Sobieskiego

Medica Pro Familia, Warsaw

Zdrowie Osteo-Medic, Wiejska

Bethesda-Spital, Basel

HFR Fribourg - Hôpital Cantonal, Fribourg

Universitätsspital Zürich, Rheumaklinik, Zurich

Sponsors
All Listed Sponsors
lead

IBSA Institut Biochimique SA

INDUSTRY

NCT02079727 - Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA | Biotech Hunter | Biotech Hunter